Related Experiment Video
Updated: Feb 9, 2026

Novel Whole-tissue Quantitative Assay of Nitric Oxide Levels in Drosophila Neuroinflammatory Response
Published on: December 4, 2013
Nrf2 Deficiency Unmasks the Significance of Nitric Oxide Synthase Activity for Cardioprotection
Ralf Erkens1, Tatsiana Suvorava1, Thomas R Sutton2,3
1Cardiovascular Research Laboratory, Division of Cardiology, Pulmonology and Vascular Medicine, Medical Faculty, Heinrich Heine University, Moorenstrasse 5, 40225 Düsseldorf, Germany.
Abstract:
The transcription factor nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is a key master switch that controls the expression of antioxidant and cytoprotective enzymes, including enzymes catalyzing glutathione de novo synthesis. In this study, we aimed to analyze whether Nrf2 deficiency influences antioxidative capacity, redox state, NO metabolites, and outcome of myocardial ischemia reperfusion (I/R) injury. In Nrf2 knockout (Nrf2 KO) mice, we found elevated eNOS expression and preserved NO metabolite concentrations in the aorta and heart as compared to wild types (WT). Unexpectedly, Nrf2 KO mice have a smaller infarct size following myocardial ischemia/reperfusion injury than WT mice and show fully preserved left ventricular systolic function. Inhibition of NO synthesis at onset of ischemia and during early reperfusion increased myocardial damage and systolic dysfunction in Nrf2 KO mice, but not in WT mice. Consistent with this, infarct size and diastolic function were unaffected in eNOS knockout (eNOS KO) mice after ischemia/reperfusion. Taken together, these data suggest that eNOS upregulation under conditions of decreased antioxidant capacity might play an important role in cardioprotection against I/R. Due to the redundancy in cytoprotective mechanisms, this fundamental antioxidant property of eNOS is not evident upon acute NOS inhibition in WT mice or in eNOS KO mice until Nrf2-related signaling is abrogated.
Insights
Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) deficiency surprisingly reduced heart attack size after ischemia/reperfusion injury. This suggests endothelial nitric oxide synthase (eNOS) upregulation may protect the heart when antioxidant capacity is low.
Area of Science:
- Cardiovascular Biology
- Molecular Medicine
- Oxidative Stress Research
Background:
- Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is a transcription factor regulating antioxidant and cytoprotective enzymes.
- Nrf2 plays a critical role in cellular defense against oxidative stress and injury.
Purpose of the Study:
- To investigate the impact of Nrf2 deficiency on myocardial ischemia/reperfusion (I/R) injury.
- To determine the role of Nrf2 in regulating antioxidative capacity, redox state, and nitric oxide (NO) metabolism during I/R.
Main Methods:
- Utilized Nrf2 knockout (Nrf2 KO) and wild-type (WT) mice to study myocardial I/R injury.
- Measured infarct size, left ventricular function, eNOS expression, and NO metabolite concentrations.
- Investigated the effects of nitric oxide synthase (NOS) inhibition in Nrf2 KO and WT mice.
Main Results:
- Nrf2 KO mice exhibited smaller infarct size and preserved cardiac function post-I/R compared to WT mice.
- Nrf2 deficiency led to elevated eNOS expression and maintained NO metabolite levels.
- Inhibition of NO synthesis exacerbated myocardial damage in Nrf2 KO mice, but not in WT mice.
Conclusions:
- Upregulation of eNOS may confer cardioprotection against I/R injury, particularly under conditions of diminished antioxidant capacity.
- Nrf2-dependent antioxidant pathways can mask the protective role of eNOS under normal conditions.
- These findings highlight a potential therapeutic strategy targeting eNOS for I/R injury management.
Related Concept Videos
Nitric Oxide Signaling Pathway
ATP Synthase: Structure
Statistical Significance
Oxidation Numbers
ATP Synthase: Mechanism
Significance of Center of Mass

